Disseminating the latest cutting edge research and news in the pharmacy field, Pharmacy Times covered stories this week on a herpes zoster that may be a rare manifestation of coronavirus disease 2019 (COVID-19) and a combination regimen that may extend progression-free survival and reduce risk of progression or death in patients with newly diagnosed multiple myeloma.

Additionally, we explored the critical points of a webinar that was hosted by Pharmacy Times in recognition of Women Pharmacists Day, with key female leaders in the field guiding the conversation.

Here are the top 5 articles of the week from Pharmacy Times.

5. Link Between Insomnia, Anxiety in Mothers During COVID-19 Pandemic

Mothers are reporting high levels of COVID-19-related anxiety and increased insomnia severity, according to recent research published in Journal of Sleep Research. Read more.

4. Monday Pharmaceutical Mystery: Which Drug Caused a Patient’s Potentially Deadly Blood Clot?

A female patient aged 44 years came to the pharmacy with a prescription for 15 mg of rivaroxaban, twice per day for 21 days, and then 20 mg once per day thereafter. Upon receiving this prescription, the pharmacist filled it and recognized that it is the treatment regimen for a new blood clot. Read more.

3. Daratumumab-Based Regimen May Be Superior for First-Line Multiple Myeloma Treatment

According to results from a recent study, patients with newly diagnosed multiple myeloma who were treated with a combination regimen including daratumumab showed a longer estimated progression-free survival and significantly reduced risk of progression or death. Read more.

2. Look for Opportunities: Women Pharmacists Discuss Work-Life Balance

In recognition of Women Pharmacists Day on October 12, a multigenerational panel of 5 women, moderated by Pharmacists Moms founder Suzanne Soliman, PharmD, discussed how the pharmacy field has changed and is still changing for women. Read more.

1. Herpes Zoster Ophthalmicus Could Be Rare Manifestation of COVID-19, Possibly Caused by Stress

Although several skin manifestations have been noted in patients with COVID-19, a new editorial published in the International Journal of Dermatology suggests that a rare form of herpes zoster could be a concern for some patients. Read more.